Hepion Pharmaceuticals, Inc. (HEPA) Form 8-K — Aug 4, 2026
Hepion Pharmaceuticals closed a private placement offering on August 3, 2026, raising gross proceeds of approximately $3.06 million. The company sold 61.1 million shares of common stock and warrants to purchase an additional 61.1 million shares at a purchase price of $0.05 per security unit. The warrants have an exercise price of $0.06 per share and are exercisable for a period of five years from the issuance date. The offering was conducted under exemptions provided by Section 4(a)(2) of the Securities Act and Rule 506(b) of Regulation D.
Key figures
- Gross Proceeds
- 3055000
- Offering Price
- 0.05
- Shares Offered
- 61100000
- Warrants shares
- 61100000
- Warrant term years
- 5
- Warrant exercise price
- 0.06
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.